PharmaLex with its own panel at Biotech Atelier 2021 Conference
The appointment of Adrian Pencak demonstrates PharmaLex’s commitment to strengthening its global sales organization
Frankfurt, Germany / Fairfax, US, October 10th 2017: As at 17th July, 2017, the PharmaLex Group, a leading specialist provider of Development Consulting, Regulatory Affairs, Quality Management & Compliance Services as well as Pharmacovigilance, has further enhanced its executive management team with the addition of an experienced business development professional.
Adrian Pencak joins PharmaLex as Executive Vice President, Business Development and Marketing. Adrian is based in the US and has a successful record of over 25 years in global business development, marketing and operations in the life sciences and healthcare industries. He joins PharmaLex from ICON and is an expert in building high performance teams that listen to client needs to ensure value is provided and their resources are optimized to save time and money.
“I am very excited to have joined the PharmaLex management team”, explained Adrian. “We are a company with ambitious growth targets as well as extremely high standards of service. I’m looking forward to playing a key role in our continued growth and success, with a special focus on the US”, he added. “Adrian’s appointment demonstrates our commitment to developing our global infrastructure and sales” explained Dr. Thomas Dobmeyer, CEO at PharmaLex. “Alongside his strong business development experience, Adrian’s background in the IT space will also support our Artificial Intelligence and innovative led services” explained Dr. Tilo Netzer, CEO at PharmaLex. “This is a key focus for us and his knowledge in this area is invaluable”, he added.
The PharmaLex Group now has over 650 employees, with 25 offices in 14 countries and more than 600 satisfied clients worldwide.
-Ends-
About PharmaLex <Confidence beyond compliance>:
PharmaLex is one of the largest providers for Development Consulting, Regulatory Affairs, Quality Management & Compliance and Pharmacovigilance worldwide. Our global teams of experts can take you through early strategic planning activities and nonclinical requirements to clinical development, through regulatory submission processes and finally guide you to market approval and product maintenance post-launch activities. We strive to deliver exceptional results — going above and beyond the standard to deliver tailor-made solutions. We aim to exceed your expectations and live by our values – flexibility, efficiency, passion & dedication.
For further information, please contact:
Ms. Eva Keck
PharmaLex GmbH; Director Business Development Operations
eva.keck@pharmalex.com
+49 621 18 15 38 0
Harrlachweg 6; 68163 Mannheim
Germany
Related posts
